Rinaldi Day, a clinical fellow from London, and Eric Dian, a rheumatologist from Summit, New Jersey, dive into the cutting-edge insights from the ACR Annual Meeting. They discuss a pivotal study linking steroid use to cardiovascular events in rheumatoid arthritis and share findings on optimizing treatment for giant cell arteritis. The conversation touches on racial biases in lung function calculations and the disparities in medication outcomes for connective tissue diseases, highlighting the urgent need for improved management strategies and monitoring.
